drugset / Trial / NCT05247385

Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel

NCT05247385

Phase 4 Completed 87 enrolled University of Sao Paulo
RandomizedParallel-groupTriple-blindTreatment

Summary

Prospective, single-center, double blind, double dummy, randomized trial. Platelet function tests and adenosine levels were assessed at baseline and 15 days after taking Ticagrelor with Prasugrel placebo or Prasugrel with Ticagrelor placebo in stable patients with coronary artery disease

Timeline

Start
2017-03-20
Primary completion
2021-02-26
Completion
2021-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prasugrel Small molecule 10 mg
Comparator Ticagrelor Small molecule 90 mg